Health Care Resources and Costs for Treating Peripheral Artery Disease in a Managed Care Population: Results From Analysis of Administrative Claims Data

por Margolis, Jay, Barron, John J., Grochulski, W. Daniel
Publicado 2005

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban

por Charlton, Blake, Adeboyeje, Gboyega, Barron, John J., Grady, Deborah, Shin, Jaekyu, Redberg, Rita F.
Publicado 2018

Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients

por Gunturu, Krishna S., Pham, Timothy T., Shambhu, Sonali, Fisch, Michael J., Barron, John J., Debono, David
Publicado 2022

A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data

por Kern, David M, Barron, John J, Wu, Bingcao, Ganetsky, Alex, Willey, Vincent J, Quimbo, Ralph A, Fisch, Michael J, Singer, Joseph, Nguyen, Ann, Mamtani, Ronac
Publicado 2017

Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

por Power, Thomas P, Ke, Xuehua, Zhao, Zhenxiang, Bonine, Nicole Gidaya, Cziraky, Mark J, Grabner, Michael, Barron, John J, Quimbo, Ralph, Vangerow, Burkhard, Toth, Peter P
Publicado 2018